NanoVibronix to Present at Dawson James Securities 4th Annual Small Cap Growth Conference
October 22 2018 - 4:47PM
NanoVibronix, Inc., (NASDAQ: NAOV), a medical
device company utilizing the Company’s proprietary and patented low
intensity surface acoustic wave (SAW) technology, today announced
that Brian Murphy, Chief Executive Officer, will be presenting at
the Dawson James Securities 4th Annual Small Cap Growth Conference
on Tuesday, October 30th, at 4:00 PM, Eastern Time, at the Wyndham
Grand Hotel in Jupiter, Florida.
About Dawson James
Securities
Dawson James Securities, Inc., a member of
FINRA/SIPC, is a full-service investment bank headquartered in Boca
Raton, FL. http://www.dawsonjames.com.
About NanoVibronix
NanoVibronix Inc. (NASDAQ: NAOV) is a medical device company
headquartered in Elmsford, NY with research and development in
Nesher, Israel, that is focused on developing medical devices
utilizing its proprietary and patented low intensity surface
acoustic wave technology. The company's technology allows for the
creation of low-frequency ultrasound waves that can be utilized for
a variety of medical applications, including the disruption of
biofilms and bacteria colonization, as well as providing pain
relief. The devices can be administered at home, without the
assistance of medical professionals. The company's primary products
include PainShield®, UroShield™ and WoundShield™. Additional
information about the company is available at:
www.nanovibronix.com.
Investor Contacts:Crescendo
Communicationsnaov@crescendo-ir.com(212) 671-1021
NanoVibronix (NASDAQ:NAOV)
Historical Stock Chart
From Jun 2024 to Jul 2024
NanoVibronix (NASDAQ:NAOV)
Historical Stock Chart
From Jul 2023 to Jul 2024